Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: A cause for concern

Lancet

Volumn 366, Issue 9492, 2005, Pages 1175-1181

  Bright, Rick A ^a   Medina, Marie Jo ^a   Xu, Xiyan ^a   Perez Oronoz, Gilda ^a   Wallis, Teresa R ^a   Davis, Xiaohong M ^a   Povinelli, Laura ^b   Cox, Nancy J ^a   Klimov, Alexander I ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b WISCONSIN STATE LABORATORY OF HYGIENE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMANTANE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; ASIA; CONTROLLED STUDY; DATA ANALYSIS; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ORGANIZATION; INFLUENZA VIRUS A; M2 GENE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRAL GENETICS; VIRUS GENE; VIRUS ISOLATION; VIRUS MUTANT; VIRUS MUTATION; VIRUS STRAIN; WORLD HEALTH ORGANIZATION;

EID: 25844438380     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)67338-2     Document Type: Article

References (36)

1. RB Belshe, MH Smith, CB Hall, R Betts, AJ Hay Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection J Virol 62 1988 1508 1512
2. R Dolin, RC Reichman, HP Madore, R Maynard, PN Linton, J Webber-Jones A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection N Engl J Med 307 1982 580 584
3. RL Tominack, FG Hayden Rimantadine hydrochloride and amantadine hydrochloride use in influenza A virus infections Infect Dis Clin North Am 1 1987 459 478
4. C Wang, K Takeuchi, LH Pinto, RA Lamb Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block J Virol 67 1993 5585 5594
5. PD Reuman, DI Bernstein, MC Keefer, EC Young, JR Sherwood, GM Schiff Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A Antiviral Res 11 1989 27 40
6. SW Younkin, RF Betts, FK Roth, RG Douglas Jr Reduction in fever and symptoms in young adults with influenza A/Brazil/78 H1N1 infection after treatment with aspirin or amantadine Antimicrob Agents Chemother 23 1983 577 582
7. JS Oxford, A Galbraith Anti influenza virus activity of amantadine Viral Chemother 1 1984 169 252
8. FG Hayden, RB Belshe, RD Clover, AJ Hay, MG Oakes, W Soo Emergence and apparent transmission of rimantadine-resistant influenza A virus in families N Engl J Med 321 1989 1696 1702
9. WJ Bean, SC Threlkeld, RG Webster Biologic potential of amantadine-resistant influenza A virus in an avian model J Infect Dis 159 1989 1050 1056
10. C Sweet, FG Hayden, KJ Jakeman, S Grambas, AJ Hay Virulence of rimantadine-resistant human influenza A (H3N2) viruses in ferrets J Infect Dis 164 1991 969 972
11. G Boivin, N Goyette, H Bernatchez Prolonged excretion of amantadine-resistant influenza a virus quasi species after cessation of antiviral therapy in an immunocompromised patient Clin Infect Dis 34 2002 E23 E25
12. AJ Hay, MC Zambon, AJ Wolstenholme, JJ Skehel, MH Smith Molecular basis of resistance of influenza A viruses to amantadine J Antimicrob Chemother 8 suppl B 1986 19 29
13. J Degelau, SK Somani, SL Cooper, DR Guay, KB Crossley Amantadine-resistant influenza A in a nursing facility Arch Intern Med 152 1992 390 392
14. JA Englund, RE Champlin, PR Wyde Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults Clin Infect Dis 26 1998 1418 1424
15. FG Hayden, SJ Sperber, RB Belshe, RD Clover, AJ Hay, S Pyke Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine Antimicrob Agents Chemother 35 1991 1741 1747
16. FG Hayden, AJ Hay Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine Curr Top Microbiol Immunol 176 1992 119 130
17. P Houck, M Hemphill, S LaCroix, D Hirsh, N Cox Amantadine-resistant influenza A in nursing homes. Identification of a resistant virus prior to drug use Arch Intern Med 155 1995 533 537
18. EE Mast, MW Harmon, S Gravenstein Emergence and possible transmission of amantadine-resistant viruses during nursing home outbreaks of influenza A (H3N2) Am J Epidemiol 134 1991 988 997
19. AI Klimov, E Rocha, FG Hayden, PA Shult, LF Roumillat, NJ Cox Prolonged shedding of amantadine-resistant influenzae A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis J Infect Dis 172 1995 1352 1355
20. K Shiraishi, K Mitamura, Y Sakai-Tagawa, H Goto, N Sugaya, Y Kawaoka High frequency of resistant viruses harboring different mutations in amantadine-treated children with influenza J Infect Dis 188 2003 57 61
21. RB Belshe, B Burk, F Newman, RL Cerruti, IS Sim Resistance of influenza A virus to amantadine and rimantadine: results of one decade of surveillance J Infect Dis 159 1989 430 435
22. M Valette, JP Allard, M Aymard, V Millet Susceptibilities to rimantadine of influenza A/H1N1 and A/H3N2 viruses isolated during the epidemics of 1988 to 1989 and 1989 to 1990 Antimicrob Agents Chemother 37 1993 2239 2240
23. T Ziegler, ML Hemphill, ML Ziegler Low incidence of rimantadine resistance in field isolates of influenza A viruses J Infect Dis 180 1999 935 939
24. H Masuda, H Suzuki, H Oshitani Incidence of amantadine-resistant influenza A viruses in sentinel surveillance sites and nursing homes in Niigata, Japan Microbiol Immunol 44 2000 833 839
25. CDC/WHO Avian Influenza Response Team Outbreaks of avian influenza A (H5N1) in Asia and interim recommendations for evaluation and reporting of suspected cases - United States, 2004 MMWR Morb Mortal Wkly Rep 53 2004 97 100
26. P Puthavathana, P Auewarakul, PC Charoenying Molecular characterization of the complete genome of human influenza H5N1 virus isolates from Thailand J Gen Virol 86 2005 423 433
27. X Xu, CB Smith, BA Mungall Intercontinental circulation of human influenza A(H1N2) reassortant viruses during the 2001-2002 influenza season J Infect Dis 186 2002 1490 1493
28. China Nonprescription Medicines Association The active ingredients of the OTC products as of September, 2002 http://en.cnma.org.cn (accessed Sept 8, 2005)
29. Ministry of Health Russian Federation Order N 287, List of medications allowed to be sold without prescriptions http://www.webapteka.ru/phdocs/doc22. html 1999 (accessed April 15, 2005)
30. NJ Cox, TL Brammer, HL Regnery Influenza: global surveillance for epidemic and pandemic variants Eur J Epidemiol 10 1994 467 470
31. Cases of influenza A (H5N1) - Thailand, 2004 MMWR Morb Mortal Wkly Rep 53 2004 100 103
32. Y Guan, LL Poon, CY Cheung H5N1 influenza: a protean pandemic threat Proc Natl Acad Sci U S A 101 2004 8156 8161
33. KS Li, Y Guan, J Wang Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia Nature 430 2004 209 213
34. JS Peiris, WC Yu, CW Leung Re-emergence of fatal human influenza A subtype H5N1 disease Lancet 363 2004 617 619
35. TH Tran, TL Nguyen, TD Nguyen Avian influenza A (H5N1) in 10 patients in Vietnam N Engl J Med 350 2004 1179 1188
36. N Viseshakul, R Thanawongnuwech, A Amonsin The genome sequence analysis of H5N1 avian influenza A virus isolated from the outbreak among poultry populations in Thailand Virology 328 2004 169 176